Global economic impact of diabetes revealed in new study

March 16, 2015, University of East Anglia
Diabetes reduces people's employment chances and wages around the world -- according to a new study from the University of East Anglia.Researchers studied the economic impact of type II diabetes worldwide. While it is widely known that diabetes poses a huge health challenge, awareness of its impact on the global economy and labor markets has never before been studied in such detail. Credit: University of East Anglia

Diabetes reduces people's employment chances and wages around the world - according to a new study from the University of East Anglia, supported by the Centre for Diet and Activity Research (CEDAR).

Researchers studied the of type II worldwide.

They were surprised to find not only a large cost burden in high-income countries, but also in low and middle-income countries - where people with diabetes and their families face high for treatment.

While it is widely known that diabetes poses a huge challenge, awareness of its impact on the global economy and labour markets has never before been studied in such detail.

The research team looked at data from 109 studies in the largest and most up-to-date global review of the economic impact of diabetes.

Headline figures:

  • People with diabetes in the US have the highest healthcare costs - with an estimated lifetime cost of around $283,000. These costs are higher than in others countries with comparable per capita income levels.
  • Worldwide, diabetes hits the poor hardest - with a higher cost burden for people in low and middle income countries.
  • Two thirds of all new cases of diabetes are now in low and middle income countries such as China, India, Mexico, and Egypt.
  • Men with diabetes have worse employment opportunities globally. The impact for women appears to be less adverse - except for in the US, where their employment chances decreased by almost half.
  • The costs associated with diabetes increase over time with disease severity.

Lead researcher Till Seuring, from UEA's Norwich Medical School said: "Diabetes affects 382 million people worldwide, and that number is expected to grow to 592 million by 2035. It is a chronic disease that has spread widely in recent decades - not only in , but also in many populous low and such as India and China.

"The rising prevalence of diabetes in these countries has been fuelled by rapid urbanization, changing eating habits, and increasingly sedentary lifestyles."

Credit: University of East Anglia

The review provides detailed information about both direct costs of the disease, such as doctor and hospital visits, medication, lab costs for tests, and equipment costs, as well as indirect costs such as income losses due to early retirement, and lost work hours due to illness.

"The characteristics of the vary from country to country depending on the health care system in place. In high income countries the burden often affects government or public health insurance budgets while in poorer countries a large part of the burden falls on the person with diabetes and their family due to very limited health insurance coverage.

"Our results show a considerable impact of diabetes in terms of costs to society, health systems, individuals and employers.

"This research provides a comprehensive picture of the economic impact of diabetes in poorer countries. The results show that people in these countries are the worst off because the economic burden on their livelihoods is much greater.

"Our findings underline the fact that diabetes not only has strong adverse effects on people's health but also presents a large - and at least partly avoidable - economic burden.

"We also found that the economic burden of diabetes increases over time. So early investments into prevention and disease management may therefore be particularly worthwhile.

"For both rich and poor countries, the results mean that better prevention and management of diabetes has the potential to not only bring good health but also economic gains.

"We would hope that the findings further increase the policy attention being paid to and management in rich countries and it should in particular make health and economic policymakers in developing countries aware of the economic damage that diabetes can do."

Explore further: TB-diabetes co-epidemic looms, experts warn

More information: 'The economic costs of type 2 diabetes: a global systematic review' is published in PharmacoEconomics:

Related Stories

TB-diabetes co-epidemic looms, experts warn

October 29, 2014
A report warned Wednesday of a looming tuberculosis-diabetes epidemic as the two diseases intertwine in many countries, driven in part by a rise in unhealthy lifestyles.

Out-of-pocket costs decline for patients with diabetes

April 24, 2014
(HealthDay)—During the past decade, out-of-pocket (OOP) costs have declined for individuals with diabetes, according to research published online March 25 in Diabetes Care.

Experts to combat the potential 'health catastrophe' of deadly tuberculosis among people with diabetes

July 24, 2014
New research aims to estimate the benefits of different ways to carry out screening both patients with tuberculosis (TB) for diabetes and the other way around in parts of the world where both diseases are common.

Global epidemic of diabetes threatens to jeopardise further progress in tuberculosis control

September 4, 2014
The rapid increase in rates of type 2 diabetes* in low- and middle-income countries where tuberculosis (TB) is endemic could hamper global efforts to control and eliminate TB, according to a new three-part Series about TB ...

Obesity, type 2 diabetes epidemics spreading to developing world as more own TVs, computer

February 10, 2014
Lower income countries may soon be facing the same obesity and diabetes epidemics as their higher income counterparts. Ownership of televisions, cars and computers was recently found to be associated with increased rates ...

Recommended for you

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

Weight loss drug shows positive effect on diabetes

October 4, 2018
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction (TIMI) Study Group presented diabetes-related findings from ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.